IMMUVEN, INC.

Basic Information

60 Hazelwood Dr
Champaign, IL, 61820-7460

Company Profile

n/a

Additional Details

Field Value
DUNS: 829773550
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Engineering Cytolytic Effectors to Eliminate Virus-Infected and Cancer Cells

    Amount: $218,309.00

    Project Summary The goal of this STTR grant application is to engineer powerful NK cell-based cytolytic effector cells for therapeutic applications. The cells will combine the selectivity and specific ...

    STTR Phase I 2014 Department of Health and Human Services
  2. Soluble high-affinity T cell receptors prevent MRSA lethality

    Amount: $1,683,417.00

    DESCRIPTION (provided by applicant): Methicillin resistant Staphylococcus aureus (MRSA) and methicillin sensitive S. aureus (MSSA) are highly significant human health threats that are responsible for ...

    SBIR Phase II 2012 Department of Health and Human Services
  3. Ultrasensitive Detection Probes for Staphylococcus aureus Enterotoxins

    Amount: $297,023.00

    DESCRIPTION (provided by applicant): Staphylococcus aureus is a significant human health threat, producing exotoxins called superantigens, which are responsible for a range of diseases. S. aureus supe ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. Soluble high-affinity T cell receptors prevent MRSA lethality

    Amount: $151,529.00

    DESCRIPTION (provided by applicant): Methicillin resistant Staphylococcus aureus (MRSA) and methicillin sensitive S. aureus (MSSA) are highly significant human health threats that are responsible for ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government